Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion type Assertion NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_head.
- NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion description "[We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132), IDH2 (R140 and R172), and c-CBL (exons 8 and 9) in 62 MPN patients (52 essential thrombocythemia (ET), five polycythemia vera (PV), and five primary myelofibrosis (PMF)) negative for both JAK2 (V617F and exon 12) and MPL (exon 10) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_provenance.
- NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion evidence source_evidence_literature NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_provenance.
- NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion SIO_000772 21904853 NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_provenance.
- NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion wasDerivedFrom befree-2016 NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_provenance.
- NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_assertion wasGeneratedBy ECO_0000203 NP922474.RA3yG7RXi5FBzCInss3Nb6wbe6aoK7ZWxQc-yquO0EWcY130_provenance.